Q3
EMR — Q3 2026 Financial Report Analysis
Emerson's fiscal Q3 2026 sales rose 7% (6% underlying) to $4.87B and diluted EPS rose to $1.28 from $1.04, helped by an $82M tariff refund; adjusted EPS of $1.71 (+13%) beat guidance and full-year guidance was raised.